Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) EBT Margin (2021 - 2026)

Lucid Diagnostics filings provide 5 years of EBT Margin readings, the most recent being 1084.4% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 12024.0% to 1084.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 1226.95%, a 17934.0% decrease, with the full-year FY2025 number at 1234.26%, down 18665.0% from a year prior.
  • EBT Margin hit 1084.4% in Q4 2025 for Lucid Diagnostics, down from 866.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 369.92% in Q2 2025 to a low of 18880.26% in Q3 2022.
  • Median EBT Margin over the past 5 years was 1814.56% (2023), compared with a mean of 4081.33%.
  • Biggest five-year swings in EBT Margin: crashed -1540176bps in 2022 and later surged 1706570bps in 2023.
  • Lucid Diagnostics' EBT Margin stood at 3768.67% in 2021, then plummeted by -254bps to 13328.57% in 2022, then surged by 92bps to 1041.35% in 2023, then rose by 7bps to 964.16% in 2024, then decreased by -12bps to 1084.4% in 2025.
  • The last three reported values for EBT Margin were 1084.4% (Q4 2025), 866.42% (Q3 2025), and 369.92% (Q2 2025) per Business Quant data.